Mason Stephen M's Form 4 filing
Cardinal Health IncCAH · filed Aug 19, 2025
- Accession no.
- 0000721371-25-000097
- Filed
- Aug 19, 2025
- Trade date
- Aug 15-19, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $6.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mason Stephen MCIK 0001786065 | Officer (CEO, GMPD Segment) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | Common Shares | AGrant or awardAcquired | +8,957 | $0.00 | $0 | 98,471 | Direct | |
| Aug 15, 2025 | Common Shares | FTax withholdingDisposed | −30,811 | $150.22F3 | −$4,628,428.42 | 67,660 | Direct | |
| Aug 19, 2025 | Common Shares | SSaleDisposed | −2,997 | $147.87F4 | −$443,166.39 | 64,663 | Direct | |
| Aug 19, 2025 | Common Shares | SSaleDisposed | −34,411 | $148.83F5 | −$5,121,389.13 | 30,252 | Direct | |
| Aug 19, 2025 | Common Shares | SSaleDisposed | −4,167 | $149.39F6 | −$622,508.13 | 26,085 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Reflects closing price on prior business day.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.30 to $148.29, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4, 5, and 6 to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.30 to $149.29, inclusive.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.30 to $149.58, inclusive.
Referenced by the price of 1 transaction in Table I.